Japan Obesity & Metabolic Syndrome Study (JOMS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.

Japan Obesity & Metabolic Syndrome Study (JOMS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization. - Japan Obesity & Metabolic Syndrome Study (JOMS)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000559

Enrollment

500

Registered

2006-12-25

Start date

2005-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Diet (25kcal/kg of ideal body weight per day) and Exercise (more than 30 minutes at moderate intensity at least 3 times per week) therapy for a maximum period of 5 years according to the Japanese Soci

s Guidelines for the treatment of Obesity patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Obese patients, Body Mass Index (BMI) is more than 25.

Exclusion criteria

Exclusion criteria: Severe Liver Dysfunction and Liver cirrhosis Severe Renal Dysfunction

Design outcomes

Primary

Measure	Time frame
The success rate of weight reduction. Detection of the influencing factors in the success rate.	—

Secondary

Measure	Time frame
The rate and its characteristic of the Metabolic Syndrome in Japanese Obese patients adn its cheracteristic. The effects ofweight reduction in preventing the progression of arteriosclerosis (Pulse Wave Velocity: PWV & CAVI) and the onset of cardiovascular disease.	—

Countries

Japan

Contacts

Public ContactNoriko Satoh

Clinical Research Institute, National Hospital Organization, Kyoto M Division of Metabolic Research

nsato@kyotolan.hosp.go.jp075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Japan Obesity &amp; Metabolic Syndrome Study (JOMS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.